Jiangsu Lianhuan Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2021: 0.00%

Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) has an Asset Resilience Ratio of 0.00% as of September 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥81.18K

≈ $11.88K USD Cash + Short-term Investments

Total Assets

CN¥2.21 Billion

≈ $322.87 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2020)

This chart shows how Jiangsu Lianhuan Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See Jiangsu Lianhuan Pharmaceutical Co Ltd shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Jiangsu Lianhuan Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Jiangsu Lianhuan Pharmaceutical Co Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥81.18K	0.0%
Total Liquid Assets	CN¥81.18K	0.00%

Asset Resilience Insights

Limited Liquidity: Jiangsu Lianhuan Pharmaceutical Co Ltd maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Jiangsu Lianhuan Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jiangsu Lianhuan Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Zhejiang Huahai Pharmaceutical Co Ltd SHG:600521	Drug Manufacturers - Specialty & Generic	0.44%
Emcure Pharmaceuticals Ltd NSE:EMCURE	Drug Manufacturers - Specialty & Generic	1.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Ningbo Menovo Pharm Co Ltd SHG:603538	Drug Manufacturers - Specialty & Generic	2.69%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	20.24%
Hunan Warrant Pharmaceutical Co. Ltd. A SHG:688799	Drug Manufacturers - Specialty & Generic	0.40%

Annual Asset Resilience Ratio for Jiangsu Lianhuan Pharmaceutical Co Ltd (2000–2020)

The table below shows the annual Asset Resilience Ratio data for Jiangsu Lianhuan Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2020-12-31	0.00%	CN¥38.43K ≈ $5.62K	CN¥2.05 Billion ≈ $299.84 Million	0.00pp
2019-12-31	0.00%	CN¥45.18K ≈ $6.61K	CN¥1.89 Billion ≈ $276.51 Million	0.00pp
2018-12-31	0.00%	CN¥41.85K ≈ $6.12K	CN¥1.42 Billion ≈ $207.80 Million	0.00pp
2017-12-31	0.00%	CN¥51.48K ≈ $7.53K	CN¥1.16 Billion ≈ $170.40 Million	0.00pp
2016-12-31	0.00%	CN¥52.29K ≈ $7.65K	CN¥1.07 Billion ≈ $156.03 Million	0.00pp
2015-12-31	0.01%	CN¥54.45K ≈ $7.97K	CN¥1.00 Billion ≈ $146.41 Million	-0.04pp
2014-12-31	0.05%	CN¥305.78K ≈ $44.75K	CN¥658.96 Million ≈ $96.43 Million	+0.02pp
2013-12-31	0.03%	CN¥179.80K ≈ $26.31K	CN¥649.48 Million ≈ $95.04 Million	-0.02pp
2012-12-31	0.05%	CN¥218.82K ≈ $32.02K	CN¥443.21 Million ≈ $64.86 Million	0.00pp
2011-12-31	0.05%	CN¥218.27K ≈ $31.94K	CN¥418.52 Million ≈ $61.24 Million	-0.01pp
2010-12-31	0.06%	CN¥234.78K ≈ $34.36K	CN¥401.08 Million ≈ $58.69 Million	-0.07pp
2009-12-31	0.13%	CN¥510.75K ≈ $74.74K	CN¥383.36 Million ≈ $56.10 Million	+0.08pp
2008-12-31	0.06%	CN¥208.76K ≈ $30.55K	CN¥359.66 Million ≈ $52.63 Million	+0.00pp
2007-12-31	0.06%	CN¥206.85K ≈ $30.27K	CN¥357.66 Million ≈ $52.34 Million	+0.03pp
2006-12-31	0.03%	CN¥94.40K ≈ $13.81K	CN¥335.84 Million ≈ $49.14 Million	-0.10pp
2004-12-31	0.13%	CN¥400.00K ≈ $58.53K	CN¥312.05 Million ≈ $45.66 Million	-0.01pp
2003-12-31	0.14%	CN¥400.00K ≈ $58.53K	CN¥293.21 Million ≈ $42.91 Million	+0.10pp
2000-12-31	0.03%	CN¥35.33K ≈ $5.17K	CN¥103.67 Million ≈ $15.17 Million	--

pp = percentage points

About Jiangsu Lianhuan Pharmaceutical Co Ltd

SHG:600513 China Drug Manufacturers - Specialty & Generic

Market Cap

$975.78 Million

CN¥6.67 Billion CNY

Market Cap Rank

#9275 Global

#2523 in China

Share Price

CN¥23.36

Change (1 day)

+2.55%

52-Week Range

CN¥9.04 - CN¥30.75

All Time High

CN¥30.75